Skip to content

Arthrodesis versus endoprosthesis - a prospective randomized trial for Hallux rigidus

Arthrodesis versus endoprosthesis - a prospective randomized trial for Hallux rigidus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000133
Enrollment
60
Registered
2009-06-04
Start date
2009-07-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M20.2

Interventions

Group 1: Arthrodesis (Fusion of the 1st metatarsophalangeal joint) Group 2: Prosthesis (Implantation of an arthroplasty)

Sponsors

Orthopädische Universitätsklinik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. male or female, 30 through 75 years 2. patients with arthrosis of the big toe base joint in stage 2 to 4 3. patients with 30 minutes stretch of way 4. the qualified patient approves the attendance to the study by signing the dated declaration of consent 5. the patient stands by for a follow up at least one year 6. the patient is in a stable state of health having or is concerned with no diseases (cardial, pulmonal, hemic diseases or others), that would be a unacceptable high risk regarding the operation.

Exclusion criteria

Exclusion criteria: 1. patients with deficient known bone substance by diseases like chancer, osteotomy in os metatarsale or the proximal phalanx or diseases with metabolic disorder that lead to tissue calcification. patients in certain physical condition like pathological overweight (BMI > 30). 2. patients with active local or systemic infections 3. patients that were operated at the same location before 4. immunodeficiency - immune defects are chronic conditions that obviously reduce the patients ability to react on antigen stimulation. for example patients that are treated by immunosuppressive drugs (high dosed corticosteroids, cytostatic agents, high doses of anti lymphocyte serum or radiation) are afflicted with immunodeficiency, also patients that are immune suppressed to avoid rejection reaction against homologous transplants, and also patients with acquired immune deficiency syndrom (AIDS) or autoimmune diseases (except rheumatoid arthritis). 5. Pregnancy (exclusion by anamnesis or if necessary by pregnancy test). 6. Patients that take part at other clinical studies testing pharmaceuticals, biological substances or medicine devices. 7. Patients whose hallux-angle amounts > 25 °.

Design outcomes

Primary

MeasureTime frame
visual analogue scale of post-operative pain with a questionnaire 1 year postoperatively

Countries

Germany

Contacts

Public ContactMarkus Wünschel

Orthopädische Universitätsklinik

markus.wuenschel@med.uni-tuebingen.de07071-2986040

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026